Common Stock, Shares, Outstanding of Monte Rosa Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Monte Rosa Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Monte Rosa Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 61,790,239, a 0.67% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Monte Rosa Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 61,790,239 +412,755 +0.67% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 61,717,349 +389,067 +0.63% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 61,509,821 +11,309,517 +23% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 61,507,446 +11,367,213 +23% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 61,377,484 +11,311,804 +23% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 61,328,282 +11,735,803 +24% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 50,200,304 +839,320 +1.7% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 50,140,233 +816,702 +1.7% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 50,065,680 +1,692,899 +3.5% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 49,592,479 +2,907,821 +6.2% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 49,360,984 +2,730,273 +5.9% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 49,323,531 +2,787,565 +6% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 48,372,781 +1,888,863 +4.1% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 46,684,658 +2,080,927 +4.7% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 46,630,711 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 46,535,966 +44,850,432 +2661% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 46,483,918 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 44,603,731 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q4 2020 1,685,534 31 Dec 2020 10-K 29 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.